ResMed Inc.RMDNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+104.2%
5Y CAGR+19.0%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+104.2%/yr
vs -18.1%/yr prior
5Y CAGR
+19.0%/yr
Recent acceleration
Acceleration
+122.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.66B | +29.2% |
| 2024 | $1.29B | +130.0% |
| 2023 | $559.30M | +186.7% |
| 2022 | $195.11M | -68.5% |
| 2021 | $619.89M | -11.0% |
| 2020 | $696.32M | +82.4% |
| 2019 | $381.71M | -12.0% |
| 2018 | $433.57M | +26.6% |
| 2017 | $342.58M | -28.6% |
| 2016 | $480.10M | - |